BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tighe SP, Akhtar D, Iqbal U, Ahmed A. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. J Clin Transl Hepatol 2020;8:454-8. [PMID: 33447529 DOI: 10.14218/JCTH.2020.00012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 El-Fadaly AA, Afifi NA, El-Eraky W, Salama A, Abdelhameed MF, El-Rahman SSA, Ramadan A. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-12. [PMID: 35255766 DOI: 10.1080/08923973.2022.2047198] [Reference Citation Analysis]
2 Yan J, Nie Y, Luo M, Chen Z, He B. Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Front Pharmacol 2021;12:694475. [PMID: 34290612 DOI: 10.3389/fphar.2021.694475] [Reference Citation Analysis]
3 Gad D, El-Shora H, Fraternale D, Maricchiolo E, Pompa A, Dietz KJ. Bioconversion of Callus-Produced Precursors to Silymarin Derivatives in Silybum marianum Leaves for the Production of Bioactive Compounds. Int J Mol Sci 2021;22:2149. [PMID: 33670070 DOI: 10.3390/ijms22042149] [Reference Citation Analysis]
4 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Reference Citation Analysis]